Peregrine Pharmaceuticals (PPHM)
Create an AlertPPHM Key Stats
| Income Statement | |
| Revenue TTM | 19.49M |
| Revenue Quarterly YoY Growth | 114.5% |
| EPS Diluted TTM | -0.30 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -32.21M |
| Profitability | |
| Gross Profit Margin Quarterly | 48.13% |
| Profit Margin Quarterly | -69.81% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 206.35M |
| Enterprise Value | 180.10M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 11.86 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -6.929M |
| Return on Equity | -285.7% |
PPHM News
- Preliminary Russell 3000 Addition Pushing Stocks Around Street Insider Jun 17
- StreetInsider.com Pre-Open Movers 6/17: (KNDI) (NFLX) (AMD) Higher; (FOLD) (TEX)... Jun 17
- Has Peregrine Pharmaceuticals Finally Turned The Corner? Jun 12
- Why Peregrine Pharmaceuticals Shares Popped Jun 3
- DirecTV Entertains Hulu Bid, Pandora Slides on New Rival, and 3 Other Hot Stocks Jun 3
- PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statem... Jun 3
- Peregrine Pharma (PPHM) Moves Higher on Positve ASCO Data Street Insider Jun 3
- Encouraging Results in Breast and Pancreatic Cancers for Patients Treated With P... Jun 3
- InPlay: Peregrine Pharma reports data presented at ASCO shows promising 11.7 mon... Jun 3
- Data Presented at ASCO Shows Promising 11.7 Month Median Overall Survival in Sec... Jun 3
PPHM Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Peregrine Pharmaceuticals is up 195.5% over the last year vs S&P 500 Total Return up 25.82%, AEterna Zentaris down 29.24%, and Dendreon down 47.42%.
PPHM Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these PPHM related companies
Pro Ratings for PPHM
Pro Report PDF for PPHM
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Pro Strategies Featuring PPHM
Did Peregrine Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
PPHM Profile
Sector: Healthcare
Industry: Biotechnology
Other PPHM Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PPHM | 1.505 | -0.06 | -3.53% | 206.35M |